Fake "As Seen On" Logos: The Forbes/NYT Problem in GLP-1 Marketing

Forbes. NBC. The New York Times. CNN. USA Today. The logos line up in a neat grid on the GLP-1 telehealth homepage. "As seen on." It implies legitimacy by association. The problem is that about half of these "as seen on" claims are false, and the other half are true but meaningless. Here's how to tell the difference in three minutes.

The three kinds of "As Seen On" claims

Kind 1: The platform was genuinely covered

A journalist at the named outlet wrote about the platform. Good journalism is skeptical and specific. You can find the article by searching the outlet's site for the platform name. If the article exists, name is clearly there, and the piece was written by a staff journalist (not a sponsored content team), the claim is legitimate — although "covered" can mean anything from a positive review to an FDA warning letter investigation.

Kind 2: The platform was mentioned in passing

Real coverage, but not about the platform. Maybe the platform was one of ten providers cited in a general article about the GLP-1 industry. This is accurate but doesn't constitute the implied endorsement. It's the kind of technically-true-but-misleading claim that's common in this category.

Kind 3: No coverage at all

The claim is fabricated. The logos are there to create impressions they haven't earned. This is illegal — it's trademark misuse and deceptive advertising, both actionable at the FTC and in state courts. But it's rarely prosecuted quickly, and operators know the enforcement risk is low.

How to verify in three minutes

1. Google "[platform name] site:[outlet].com" — e.g., "SketchyHealth site:forbes.com". This searches only Forbes.com for mentions of the platform. If there's no result, the claim is almost certainly fabricated or the platform was mentioned under a different name.
2. Read the article if it exists. Is it a news article by a staff journalist? Is it a Forbes Councils contributor post (self-published, not editorial)? Is it a sponsored content piece? All three are possible, and only the first is real coverage.
3. Note the date. Coverage from 2021 that describes the platform as "promising early-stage startup" is not a 2026 endorsement. Things change.

The Forbes Councils problem specifically

Forbes has a product called Forbes Councils — a paid membership program for business executives. Members can publish articles under the Forbes brand. Forbes Councils posts are not Forbes editorial journalism. They're thinly-reviewed thought-leadership pieces the author pays to publish.

Many "As seen on Forbes" claims in the GLP-1 space trace back to a Forbes Councils post written by the platform's CEO or founder. Technically published on Forbes. Not technically news coverage.

The USA Today syndication trap

USA Today operates a network that carries syndicated content from partner outlets. A press release distributed via Business Wire or PR Newswire may appear on a USA Today partner site and trigger a claimable "USA Today network" badge. This is how you get "As seen on USA Today" without USA Today ever having written a word about the company.

Verification: search usatoday.com directly. If the article only appears on a syndicated partner site (e.g., some small-market newspaper that USA Today bought in 2020), the claim is stretchy but technically defensible.

The press release trick

PR Newswire, Business Wire, and other wire services distribute press releases that sometimes get picked up by tertiary news sites. "As seen on Associated Press" occasionally traces back to an AP distribution of a press release, not AP journalism. The AP distributes press releases as a service; that's not the same as the AP covering the company.

The "featured in" variant

"Featured in [Outlet]" is slightly softer than "As seen on" and slightly harder to verify. "Featured" could mean the platform was the subject of a feature article, or it could mean the platform was mentioned in a listicle, or it could mean the platform paid for a sponsored feature. All three describe different realities.

How to investigate properly

1. Site-specific search on each claimed outlet. "[platform name] site:forbes.com", "[platform name] site:nytimes.com", etc.
2. Check the Wayback Machine. web.archive.org. Did the logos show up on the platform's site recently or have they been there for years? New additions after negative press is a pattern worth noticing.
3. Check for a Press or Media page on the platform's site. A legitimate platform links directly to the articles. A scammy one just shows logos with no links.
4. Google Images the logo grid itself. Sometimes the same exact graphic is used by dozens of unrelated low-quality sites, traceable to a single affiliate-marketing template.

A real test — an article about this industry

The GLP-1 telehealth category has had meaningful coverage in The New York Times, Bloomberg, Reuters, STAT News, The Wall Street Journal, and Business Insider. Mostly not flattering. A platform that appears in those articles is usually named in the context of FDA scrutiny, patient safety concerns, or the general regulatory mess of 2024–2025. "As seen on The New York Times" is sometimes a platform claiming a piece about how the FDA is investigating them.

What a legitimate "press" page looks like

• Direct links to each article, not just logos.
• Article dates and author names.
• Direct quotes pulled from the articles with citations.
• A mix of outlets, including some smaller trade or industry publications (real companies get covered in industry journals before they get into Forbes).
• Reasonable recency — at least one article from the past 24 months.

What a fabricated press section looks like

• Logos only, no links.
• The biggest-possible outlets (NYT, CNN, Forbes, NBC) with no smaller industry mentions.
• No dates.
• Weirdly curated "awards" badges from organizations nobody has heard of.
• Logos for outlets that have never covered healthcare companies (e.g., "As seen on MTV").

Why this matters

The logo strategy works. Even sophisticated readers see a grid of Forbes-NBC-NYT logos and unconsciously weight it as a trust signal. That's exactly why operators use it. The five minutes it takes to verify are low-effort, high-value — and they filter out a significant chunk of the sketchier end of the category.